Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the assessment of treatment with lisinopril and survival (ATLAS) study

2004 ◽  
Vol 26 (5) ◽  
pp. 694-703 ◽  
Author(s):  
Sumit R Majumdar ◽  
Finlay A McAlister ◽  
Marilyn Cree ◽  
Wei-Ching Chang ◽  
Milton Packer ◽  
...  
Keyword(s):  
Heart Failure ◽  
Congestive Heart Failure ◽  
Enzyme Inhibitors ◽  
Secondary Analysis ◽  
Angiotensin Converting Enzyme Inhibitors ◽  
Evidence Based ◽  
Converting Enzyme ◽  
Converting Enzyme Inhibitors ◽  
Evidence Based Treatments ◽  
One Year
Sign in / Sign up

Export Citation Format

Share Document